Showing results (31-40 of 59) with videos related to
Sort By:
Pageof 6
Cancers|April 14, 2025
A Retrospective Analysis of Ambiguous Spitz Tumors Using Next-Generation SequencingMario Teufer, Martin Theiler, Joana Lanz, et al.Journal of Cutaneous Pathology|June 9, 2026
Depicting the Immunological Landscape of Basal Cell Carcinoma SubtypesIsabella Dommann, Gaetana Restivo, Isabel Kolm, et al.Cancer Cell|January 22, 2021
Oncolytic virotherapy-mediated anti-tumor response: a single-cell perspectiveEgle Ramelyte, Aizhan Tastanova, Zsolt Balázs, et al.Dermatology (Basel, Switzerland)|September 22, 2022
Swiss Recommendations for Cutaneous Basal Cell CarcinomaEgle Ramelyte, Mirjam C Nägeli, Robert Hunger, et al.Nature Reviews. Disease Primers|August 27, 2021
Cutaneous T cell lymphomaReinhard Dummer, Maarten H Vermeer, Julia J Scarisbrick, et al.Melanoma Research|December 21, 2023
Patterns of radiological response to tebentafusp in patients with metastatic uveal melanomaNatalia M Roshardt Prieto, Patrick Turko, Caroline Zellweger, et al.Cancers|March 13, 2024
Real-World Data on Clinical Outcomes and Treatment Management of Advanced Melanoma Patients: Single-Center Study of a Tertiary Cancer Center in SwitzerlandRamon Staeger, Julia M Martínez-Gómez, Patrick Turko, et al.Cancers|January 10, 2026
Neoadjuvant Therapy in Resectable Advanced Melanoma: Swiss Real-World DataAnn-Kathrin Blumenröther, Yongxing Fang, Tamara El Saadany, et al.The Oncologist|June 24, 2025
Retrospective multicenter analysis of real-life toxicity and outcome of ipilimumab and nivolumab in metastatic uveal melanomaAmélie Ciernik, Laure Ciernik, Peter Bonczkowitz, et al.Cell Reports. Medicine|June 28, 2024
Monitoring melanoma patients on treatment reveals a distinct macrophage population driving targeted therapy resistanceJelena Vasilevska, Phil Fang Cheng, Julia Lehmann, et al.Pageof 6